Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologynorthwood AED Coverage Policy Update | OpenPayer
    Ask Trek AI about this page
    CurrentnorthwoodPolicy N/A

    Automatic External Defibrillator (AED) coverage

    Customize your policy alerts

    Sign up for all northwood policy alerts

    Know when northwood releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines coverage criteria, limitations, and supporting diagnosis codes for automatic external defibrillators (wearable and non-wearable) for Northwood members; affects ordering practitioners and members meeting medical necessity criteria.

    Policy Summary
    Payernorthwood
    PolicyAutomatic External Defibrillator (AED) coverage
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2024
    Last ReviewSep 2, 2025
    Next Review DateSep 2, 2025
    Key ActionMust be ordered by the member's treating practitioner; wearable and non-wearable devices are covered only when the member meets the listed clinical criteria.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2device types
    8qualifying conditions
    multiplesupporting diagnosis groups
    definedreplacement/repair limits

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3
    HCPCS referenced
    3definitions

    Coverage Criteria and Limitations

    inv-01: Wearable defibrillator (K0606) coverage criteria

    Covered when ANY one of the following wearable-device criteria is met:

    Wearable AED criteria: (i) Documented ventricular fibrillation or a sustained ventricular tachyarrhythmia lasting 30 seconds or longer, spontaneous or induced during an EP study, not due to a transient or reversible cause and not occurring during the first 48 hours of an acute myocardial infarction.

    Must be ordered by the member's treating practitioner who is experienced in management of members at risk for sudden cardiac death.

    Wearable AED criteria: (ii) Familial or inherited conditions with a high risk of life‑threatening ventricular tachyarrhythmia (for example, long QT syndrome or hypertrophic cardiomyopathy).

    Must be ordered by the member's treating practitioner.

    Wearable AED criteria: (iii) Documented prior myocardial infarction or dilated cardiomyopathy AND a measured left ventricular ejection fraction less than or equal to 0.35.LVEF ≤ 0.35

    Reference diagnosis codes in the policy's supporting diagnosis section.

    Wearable AED criteria: (iv) A previously implanted defibrillator now requires explantation.

    Reference diagnosis codes in the policy's supporting diagnosis section.

    inv-02: Non-wearable defibrillator (E0617) coverage criteria

    Covered when EITHER both criteria (i) and (ii) are met, or criterion (iii) is met:

    Path A: both (i) and (ii)

    • Conditions 1–8: 1. Documented cardiac arrest due to ventricular fibrillation, not due to a transient or reversible cause; 2. A sustained ventricular tachyarrhythmia lasting 30 seconds or longer, spontaneous or induced during an EP study, not associated with acute myocardial infarction and not due to a transient or reversible cause; 3. Familial or inherited high‑risk conditions (e.g., long QT syndrome, hypertrophic cardiomyopathy); 4. Coronary artery disease with documented prior myocardial infarction, measured LVEF ≤ 0.35, and inducible sustained VT or VF on EP study (MI occurred >4 weeks before prescription/SWO and EP test performed >4 weeks after the qualifying MI); 5. Documented prior myocardial infarction and measured LVEF ≤ 0.30, provided the member does NOT have: (a) cardiogenic shock or symptomatic hypotension while in a stable baseline rhythm; (b) CABG or PTCA within past 3 months; (c) an enzyme‑positive MI within the past month; (d) clinical findings making them a candidate for coronary revascularization; (e) irreversible brain damage from preexisting cerebral disease; or (f) any noncardiac disease with life expectancy <1 year; 6. Ischemic dilated cardiomyopathy with prior MI, NYHA Class II–III, and measured LVEF ≤ 35%; 7. Nonischemic dilated cardiomyopathy >3 months, NYHA Class II–III, and measured LVEF ≤ 35%; 8. Members who meet one of criteria 1–7 and have NYHA Class IV heart failure.
    Path B: (iii): A previously implanted defibrillator now requires explantation.

    inv-03: Indications/Documentation/Modifier Requirements

    Coverage and documentation conditions

    KX modifier use: Supplier must add KX modifier only if all criteria in the Indications and Limitations of Coverage and/or Medical Necessity section of this policy have been met.

    Modifier required when policy criteria are met.

    Face‑to‑face exam: Treating physician must perform a face‑to‑face examination within six months prior to the written order as required by ACA 6407; documentation must be received by the supplier prior to delivery for certain DME items and must describe the medical condition for which the DME is prescribed.6 months

    Documentation must be provided before delivery for applicable DME items.

    Final coverage determination: Coverage determinations are subject to the member's contract language; a finding that a product or service is reasonable and necessary does not by itself guarantee coverage. Coverage is decided on a case‑by‑case basis and is subject to the terms, conditions, limitations, and exclusions of the member's contract.

    Devices used for diagnoses other than those specifically listed in this policy are excluded. The policy states that the efficacy of the devices has not been proven when used for diagnoses other than those listed and such uses will not be covered.

    Equipment that is used primarily and customarily for a non-medical purpose is not considered durable medical equipment. Final coverage is determined on a case-by-case basis and is subject to the member's contract terms, limitations, and exclusions; therefore, even when an item appears relevant to clinical criteria, coverage remains subject to review and the member's contract language.

    Policy history and administrative notes are reviewed annually; historical entries record reviews and coding updates (for example, a corrected HCPCS code noted in recent annual review activity). These historical notes document periodic review dates and coding adjustments but do not themselves establish additional clinical exclusions.

    Claims submitted for defibrillators for indications other than those specified in this policy will be denied as not reasonable and necessary. Providers should confirm that the patient meets the listed clinical criteria before billing to avoid denial for non-covered indications.

    Application of modifier GZ indicates that the item or service is expected to be denied as not reasonable and necessary. Suppliers and providers should use modifiers per policy instructions and only apply GZ when appropriate, recognizing that its presence signals an anticipated denial under the coverage rules.

    HCPCS, Modifiers, and Diagnosis Codes

    Covered HCPCS - WearableHCPCSCovered
    K0606Wearable defibrillator
    Covered HCPCS - Non-wearableHCPCSCovered
    E0617Non-wearable automatic defibrillator
    ICD-10 Codes that Support Medical NecessityICD-10
    I21.01ST elevation (STEMI) myocardial infarction involving left main coronary artery
    I21.02ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
    I21.09STEMI involving other coronary artery of anterior wall
    I49.01Ventricular fibrillation
    I47.21Torsades de pointes
    I25.5Ischemic cardiomyopathy
    I42.0Dilated cardiomyopathy
    I45.81Long QT syndrome
    HCPCS Covered/Device and AccessoriesHCPCSCovered
    E0617EXTERNAL DEFIBRILLATOR WITH INTEGRATED ELECTROCARDIOGRAM ANALYSIS
    K0606DURABLE MEDICAL EQUIPMENT, MISCELLANEOUS AUTOMATIC EXTERNAL DEFIBRILLATOR, WITH INTEGRATED ELECTROCARDIOGRAM ANALYSIS, GARMENT TYPE (wearable)
    A9999MISCELLANEOUS DME SUPPLY OR ACCESSORY, NOT OTHERWISE SPECIFIED (replacement supplies for E0617 per policy)
    K0607REPLACEMENT BATTERY FOR AUTOMATED EXTERNAL DEFIBRILLATOR, GARMENT TYPE ONLY, EACH
    K0608REPLACEMENT GARMENT FOR USE WITH AUTOMATED EXTERNAL DEFIBRILLATOR, EACH
    K0609REPLACEMENT ELECTRODES FOR USE WITH AUTOMATED EXTERNAL DEFIBRILLATOR, GARMENT TYPE ONLY, EACH
    A9270Other types of defibrillators (per coding guideline: other types coded as A9270)
    Diagnosis codes referenced in policy textICD-10
    I21.0ST elevation (STEMI) myocardial infarction (various subsite codes referenced across chunks)
    I25.2Old myocardial infarction
    I42.0Dilated cardiomyopathy (and related I42.x series for cardiomyopathies)
    I46.8Cardiac arrest due to other underlying condition
    I49.01Ventricular fibrillation
    T82.110ABreakdown (mechanical) of cardiac electrode, initial encounter (and related T82.x device complication codes)
    HCPCS ModifiersModifier
    EYNo physician or other health care provider order for this item or service
    GAWaiver of liability statement on file
    GZItem or service expected to be denied as not reasonable and necessary
    KXRequirements specified in the medical policy have been met
    Corrected HCPC CodeHCPCS
    E0617Corrected HCPC code for AED (was previously listed as K0617)
    ICD-10-CM codes added to Group 1 and Group 2ICD-10Covered
    I25.5Chronic ischemic heart disease
    I50.1Left ventricular failure
    I50.20Unspecified systolic (congestive) heart failure
    I50.21Acute systolic (congestive) heart failure
    I50.22Chronic systolic (congestive) heart failure
    I50.23Acute on chronic systolic (congestive) heart failure
    I50.30Unspecified diastolic (congestive) heart failure
    I50.31Acute diastolic (congestive) heart failure
    I50.32Chronic diastolic (congestive) heart failure
    I50.33Acute on chronic diastolic (congestive) heart failure
    1–10 of 25
    1/3
    Left ventricular ejection fraction (LVEF) — thresholds referenced
    LVEF thresholds used for coverageLVEF ≤ 0.35 for several wearable and non‑wearable device criteria; a more stringent threshold of LVEF ≤ 0.30 applies for one specified non‑wearable criterion (documented prior MI with LVEF ≤ 0.30)
    Measurement timing requirement (context)For certain EP‑study–related criteria, myocardial infarction and EP testing must be separated by >4 weeks when used alongside LVEF ≤ 0.35
    Associated clinical contextsLVEF thresholds appear in criteria tied to prior myocardial infarction, ischemic or nonischemic dilated cardiomyopathy, and inducible VT/VF on EP study
    Role in device type selectionLVEF thresholds help determine whether a wearable device (K0606) or non‑wearable device (E0617) meets medical necessity

    Ordering, Documentation, Modifiers, and Billing Guidance

    Prior Authorization

    Prior authorization and practitioner order required

    Coverage requires a practitioner order from the member's treating practitioner; wearable defibrillator (K0606) and non‑wearable automatic defibrillator (E0617) are covered only when the member meets the specific clinical criteria listed in the policy. The treating practitioner is expected to be experienced in managing members at risk for sudden cardiac death.

    • Device coverage is conditional on meeting the policy's medical necessity criteria.
    • Order must come from the member's treating practitioner.
    Billing Rule

    KX modifier use tied to meeting all policy criteria

    Suppliers must append the KX modifier only when all criteria in the Indications and Limitations of Coverage/Medical Necessity section of this policy have been met. Coverage determinations remain subject to the member’s contract and final benefit determination.

    Background and Clinical Context

    An automatic external defibrillator (AED) is a device capable of monitoring cardiac rhythms, detecting dysrhythmias, and delivering a shock to the heart when appropriate without user decision making. AEDs are intended for members at elevated risk of sudden cardiac death and function by continuously assessing rhythm and delivering therapy when a shockable rhythm is detected.

    Definitions

    Automatic external defibrillator (AED) definition
    AED definitionDevice capable of monitoring cardiac rhythms, detecting dysrhythmias and delivering a shock to the heart when appropriate without user decision making.
    Primary functionMonitors rhythms, detects life‑threatening dysrhythmias, and automatically delivers defibrillation shocks when indicated
    Intended populationMembers at high risk for sudden cardiac death (SCD)
    Myocardial infarction
    Myocardial infarction definitionDefined by elevated cardiac enzymes or Q‑waves on an electrocardiogram.
    Use in coverage criteriaPrior MI is an explicit qualifying condition for wearable and non‑wearable AED coverage when paired with LVEF thresholds or other requirements
    Policy Summary
    Payernorthwood
    PolicyAutomatic External Defibrillator (AED) coverage
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJan 1, 2024
    Last ReviewSep 2, 2025
    Next Review DateSep 2, 2025
    Key ActionMust be ordered by the member's treating practitioner; wearable and non-wearable devices are covered only when the member meets the listed clinical criteria.
    SourceLink
    On This Page
    Coverage Criteria and LimitationsHCPCS, Modifiers, and Diagnosis CodesOrdering, Documentation, Modifiers, and Billing GuidanceBackground and Clinical ContextDefinitions

    Reference diagnosis codes in the policy's supporting diagnosis section.

    Case‑by‑case determinations; equipment primarily for non‑medical purposes is not considered DME.

    (policy fallback) Key policy points
    Policy source fallbackWhen inventory label is empty, use policy text: AED coverage requires practitioner order and specific clinical criteria (see wearable and non‑wearable criteria)
    Key supporting statementsAutomatic external defibrillators are covered for members at high risk for sudden cardiac death; treating practitioner must be experienced in SCD management
    Documentation triggersFace‑to‑face exam within 6 months and documentation per ACA 6407 may apply (policy references documentation requirements)
    Definitions referencedDefinitions in policy detail myocardial infarction criteria, acceptable ejection fraction measurement methods, and transient/reversible causes
    • Add KX only if every policy criterion is satisfied.
    • Plan contract language and case‑by‑case determinations govern final coverage.
    Documentation Required

    Follow Medicare/LCD documentation alignment

    Policy language and edits were made to align with Medicare documentation practices; follow applicable Medicare documentation and local LCD/NCD rules when seeking authorization, including prescription/standard written order (SWO) expectations where applicable.

    • Follow Medicare LCD/NCD guidance cited in References when pursuing Medicare coverage.
    • Policy added prescription/SWO and treating practitioner language for Medicare alignment.
    Step Therapy

    Implantation must be contraindicated for specified non‑wearable criteria

    For non‑wearable device coverage paths that require implantation to be contraindicated, the policy explicitly requires that implantation surgery be contraindicated as a condition of coverage (Path A, criterion (ii)).

    • Implantation surgery must be contraindicated to meet that non‑wearable coverage pathway.
    Note

    (Reserved for additional provider actions.)

    Note

    (Reserved for referenced Medicare/LCD callouts.)

    Prior Authorization

    Order must come from the treating practitioner with SCD experience

    The device must be ordered by the member’s treating practitioner; the policy states the treating practitioner is expected to be experienced in the management of members at risk for sudden cardiac death.

    • Order must originate from the treating practitioner.
    • Practitioner should have experience managing SCD‑risk patients.
    Documentation Required

    ACA 6407 face‑to‑face exam and documentation required

    Per ACA 6407, the treating physician must perform a face‑to‑face examination within six months prior to the written order; documentation describing the medical condition must be received by the supplier prior to delivery for certain DME items.

    • Face‑to‑face exam within six months before the written order is required.
    • Supplier must receive supporting documentation before delivery for affected DME items.
    Documentation Required

    Follow current modifier (GA/GZ) and documentation practices

    Policy revisions have historically instructed use of GA and GZ modifiers and added prescription/standard written order (SWO) language; providers should follow the current modifier and documentation instructions reflected in this policy and applicable Medicare LCD/NCD guidance.

    • Historical guidance included GA/GZ modifier instructions.
    • Current practice: follow policy and applicable Medicare/LCD guidance for modifiers and documentation.
    Denial Risk

    Claims for other indications will be denied

    Claims submitted for defibrillators used for indications other than those listed in this policy will be denied as not reasonable and necessary.

    • Do not submit claims for unrelated indications; such claims will be denied.
    Denial Risk

    GZ modifier indicates expected denial

    Use of modifier GZ signals the item or service is expected to be denied as not reasonable and necessary.

    • Append GZ to indicate anticipated denial when appropriate per policy guidance.
    Billing Rule

    Use corrected HCPCS code E0617 to avoid coding mismatch

    The policy corrected an earlier HCPCS listing (K0617) to the proper code E0617; failure to use the corrected HCPCS code may cause claim processing issues or denials.

    • Update claims to use E0617 (corrected code) for the non‑wearable device.
    • Incorrect/legacy coding may trigger denials or processing errors.
    Timing considerationsSome non‑wearable criteria require the MI to have occurred >4 weeks before defibrillator prescription and EP testing to be >4 weeks after the MI
    Ejection fraction measurement — acceptable methods
    Acceptable measurement methodsEjection fraction must be measured by angiography, radionuclide scanning, or echocardiography.
    Context of useMeasured LVEF values (≤0.35 or ≤0.30) referenced in multiple coverage criteria must come from an accepted measurement modality
    Associated diagnosesMeasured EF used to qualify members with prior MI or dilated cardiomyopathy for wearable or non‑wearable AED coverage
    Transient or reversible causes — examples
    Examples of transient or reversible causesIncludes drug toxicity, severe hypoxia, acidosis, hypokalemia, hypercalcemia, hyperkalemia, systemic infections, and myocarditis (not all‑inclusive).
    Coverage relevanceDysrhythmias due to transient or reversible causes are excluded from qualifying criteria (e.g., VF/VT must not be due to such causes)
    Assessment implicationProviders must document absence of transient/reversible causes when claiming prior VF or sustained VT as qualifying events